NASDAQ:ADMA

ADMA Biologics Earning Date

USA |NASDAQ |USD

ADMA Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.14 $-0.15 $-0.19
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $18.40M $17.83M $10.28M

Adma Biologics's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

ADMA Earnings Date & History Chart

ADMA Earnings & Revenue Forecast

ADMA Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.12 $-0.14 $-0.10
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.57 $-0.63 $-0.53
Dec 2022 5 $-0.26 $-0.40 $-0.10

ADMA Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.12 $-0.12 $-0.13
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-0.58 $-0.58 $-0.57
Dec 2022 0 / 0 $-0.28 $-0.28 $-0.34

ADMA Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 5 $22.30M $20.50M $24.66M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $74.33M $71.60M $77.12M
Dec 2022 5 $114.58M $105.04M $124.19M

ADMA Earnings Date & Revenue History

ADMA Earnings History

|
Show More
Show More

ADMA Revenue History

|
Show More
Show More

Adma Biologics Next Earnings Date & Report

ADMA Next Earnings Date & Report Preview: Sep 2021 (FQ)

ADMA's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 5 analysts, the average EPS estimation for Adma Biologics's next quarterly earnings is $-0.14, with a low EPS estimation of $-0.18, and a high estimation of $-0.12.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.15, the last 2 month trend is $-0.15, and the 3 month trend is $-0.14.

Based on 5 analysts, the average revenue estimation is $18.40M, with a low revenue estimation of $16.80M, and a high estimation of $19.28M.

Adma Biologics Previous Earnings Dates & Reports

ADMA Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Adma Biologics's previous earnings date was Aug 11, 2021 for its fiscal quarter ended Jun 30, 2021.

ADMA's earnings per share (EPS) was $-0.15, beating the consensus analysts forecast of $-0.16 by 3.85%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -6.25%, and higher than the same period a year before (Jun 2020) by -34.78%.

Revenues were $17.83M, worse than the forecast of $17.83M by -0.00%, up by 11.10% from the previous quarter , and up by 128.96% from the same period last year.

The company reported a net income of $-18.91M.

Free cash flow for the quarter was $-36.74M , compared to $-35.80M last quarter and $-25.45M a year before.

ADMA ended the quarter with $101.34M in total debt, an increase of 1.18% compared to the previous quarter, and an increase of 4.70% compared to the same quarter a year before.

ADMA Previous Earnings Date & Report Recap: Dec 2020 (FY)

Adma Biologics's previous annual earnings date was Mar 25, 2021 for its fiscal year ended Dec 31, 2020.

ADMA's earnings per share (EPS) was $-0.88, missing the consensus analysts forecast of $-0.85 by 3.53% , and higher than the previous year's EPS (Dec 2019) by -2.22%.

Revenues were $42.22M, better than the forecast of $41.22M by 2.43%, and up by 43.85% from previous year's revenue.

The company reported a net income of $-75.75M.

Adma Biologics reported a free cash flow of $-114.73M for its fiscal year, compared to $-80.01M a year ago.

The company ended the fiscal year with $93.33M in total debt, an increase of 11.87% compared to the previous year.